Literature DB >> 18806630

Association of physician's sex with risk factor control in treated hypertensive patients from Swedish primary healthcare.

Gunilla Journath1, Mai-Lis Hellénius, Karin Manhem, Karin I Kjellgren, Peter M Nilsson.   

Abstract

OBJECTIVE: To study the association of physician's sex with blood pressure, lipid control, and cardiovascular risk factors in treated hypertensive men and women, stratified for the sex of their physician.
METHODS: In a cross-sectional survey of hypertensive patients, 264 primary care physicians (PCPs), 187 men and 77 women from across Sweden, recruited 6537 treated hypertensive patients (48% men) during 2002-2005, consecutively collected from medical records and registered on a web-based form connected to a central database. Patients were included consecutively in the same order as they visited the healthcare centre.
RESULTS: Hypertensive women more often reached target systolic/diastolic blood pressure levels (<140/90 mmHg) when treated by female PCPs than when they were treated by male PCPs (32 vs. 24%, P < 0.001). This difference remained when comparing female and male physicians' nondiabetic female patients. Both male and female patients had better control of total cholesterol and low-density lipoprotein cholesterol levels when treated by female PCPs than when treated by male PCPs (total cholesterol <5 mmol/l: women 30 vs. 24%, P < 0.001; men 42 vs. 34%, P < 0.001; low-density lipoprotein cholesterol <3 mmol/l: women 39 vs. 33%, P < 0.01; men 41 vs. 35%, P < 0.05). Female PCPs had a higher proportion of treated hypertensive patients with diabetes than did male PCPs but male PCPs had a higher prevalence of treated hypertensive men with microalbuminuria compared with female PCPs.
CONCLUSION: Female physicians appeared more often to reach the treatment goal for blood pressure in female patients and cholesterol levels in all patients than did male physicians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806630     DOI: 10.1097/HJH.0b013e32830a4a3b

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Sex and gender differences in health. Science & Society Series on Sex and Science.

Authors:  Vera Regitz-Zagrosek
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

2.  Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD).

Authors:  C Ljungman; T Kahan; L Schiöler; P Hjerpe; B Wettermark; K B Boström; K Manhem
Journal:  J Hum Hypertens       Date:  2014-11-06       Impact factor: 3.012

3.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

4.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

5.  Physician Gender and Lifestyle Counselling to Prevent Cardiovascular Disease: A Nationwide Representative Study.

Authors:  Katharina Diehl; Dirk Gansefort; Raphael M Herr; Tatiana Görig; Christina Bock; Manfred Mayer; Sven Schneider
Journal:  J Public Health Res       Date:  2015-07-16

6.  COPD management by Swedish general practitioners - baseline results of the PRIMAIR study.

Authors:  Hanna Sandelowsky; Natalia Natalishvili; Ingvar Krakau; Sonja Modin; Björn Ställberg; Anna Nager
Journal:  Scand J Prim Health Care       Date:  2018-01-15       Impact factor: 2.581

7.  The impact of general practitioners' gender on process indicators in Hungarian primary healthcare: a nation-wide cross-sectional study.

Authors:  Nóra Kovács; Orsolya Varga; Attila Nagy; Anita Pálinkás; Valéria Sipos; László Kőrösi; Róza Ádány; János Sándor
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.